Skip to main content

DAVITA INC.

For the period ended Mar 31, 2026. Filed May 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 5, 2026

DVA$191.35-1.8%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Income for the three months ended and March 31, 2025

CONSOLIDATED STATEMENTS OF INCOME

Three months ended March 31,
20262025
Dialysis patient service revenues$3,272,797$3,102,993
Other revenues142,751120,536
Total revenues3,415,5483,223,529
Operating expenses:
Patient care costs2,342,2572,239,660
General and administrative421,914374,090
Depreciation and amortization177,829176,451
Equity investment income, net(8,344)(5,609)
Total operating expenses2,933,6562,784,592
Operating income481,892438,937
Debt expense(145,131)(135,055)
Other income (loss), net4,473(17,549)
Income before income taxes341,234286,333
Income tax expense66,19954,117
Net income275,035232,216
Less: Net income attributable to noncontrolling interests(77,505)(69,299)
Net income attributable to DaVita Inc.$197,530$162,917
Earnings per share attributable to DaVita Inc.:
Basic net income$2.93$2.05
Diluted net income$2.87$2.00
Weighted average shares for earnings per share:
Basic shares67,39079,368
Diluted shares68,87581,275
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.